Verona Pharma plc buy Wedbush
Start price
19.10.23
/
50%
€0.51
Target price
19.10.24
€31.16
Performance (%)
-
End price
20.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | -1,11 % | 0,20 % | 1,21 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % | 25,87 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % | 50,97 % |
| iShares S&P 500 | -1,79 % | 0,99 % | 21,07 % |
Comments by Wedbush for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Wedbush gewählte maximale Laufzeit wurde überschritten